Fusion proteins based upon somatostatin receptors
CA 2437799 A1 · Owner: Board Of Regents, The University Of Texas System · Inventors: Kundra, Vikas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to fusion proteins that can be used to assay gene transfer and expression both <I> in vitro</I> and <I>in vivo</I>. The fusion proteins contain a reporter protein e.g. a somatostatin receptor, fused to a second protein which may be a protein fusion tag. Alternatively a , fusion protein may be fused to a leader sequence. A leader sequence may localize an expressed protein, e.g. localize a fusion protein to the cell membrane. The invention includes acids encoding the fusion proteins and methods of assaying for gene expression.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 15, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 15, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 15, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.